Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. (BDTX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · BDTX · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Black Diamond Therapeutics, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
BDTX insider buying and selling by quarter
BDTX insider selling · BDTX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · BDTX ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
BDTX executive sell shares · BDTX board member insider trading · BDTX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 20, 2026 | Behbahani Ali Director | Award | 6,919 | $15K | Form 4 |
| Mar 20, 2026 | Raman Prakash Director | Award | 6,105 | $13K | Form 4 |
| Dec 12, 2025 | Behbahani Ali Director | Award | 5,208 | $14K | Form 4 |
| Dec 12, 2025 | Raman Prakash Director | Award | 4,665 | $13K | Form 4 |
| Sep 19, 2025 | Behbahani Ali Director | Award | 4,291 | $14K | Form 4 |
| Sep 19, 2025 | Raman Prakash Director | Award | 3,843 | $13K | Form 4 |
| Jun 20, 2025 | Behbahani Ali Director | Award | 6,170 | $14K | Form 4 |
| Jun 20, 2025 | Raman Prakash Director | Award | 5,526 | $13K | Form 4 |
| Mar 21, 2025 | Behbahani Ali Director | Award | 7,646 | $14K | Form 4 |
| Mar 21, 2025 | Raman Prakash Director | Award | 6,848 | $13K | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V 10 percent owner | Sale | 1,000,000 | $2.07M⚡ | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V 10 percent owner | Sale | 300,000 | $583K | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V 10 percent owner | Sale | 1,000,000 | $2.31M⚡ | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V 10 percent owner | Sale | 2,000,000 | $4.00M⚡ | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V 10 percent owner | Sale | 400,000 | $837K | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V 10 percent owner | Sale | 584,292 | $1.14M⚡ | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V 10 percent owner | Sale | 500,000 | $1.06M⚡ | Form 4 |
| Jan 30, 2025 | Velleca Mark A. PRESIDENT & CEO · Director | Award | 75,000 | — | Form 4 |
| Jan 30, 2025 | Yurasov Sergey CHIEF MEDICAL OFFICER | Award | 75,000 | — | Form 4 |
| Jan 30, 2025 | Buck Elizabeth CHIEF SCIENTIFIC OFFICER | Award | 75,000 | — | Form 4 |
| Jan 30, 2025 | Jones Erika SEE REMARKS | Award | 75,000 | — | Form 4 |
| Jan 30, 2025 | Hatzis-Schoch Brent SEE REMARKS | Award | 75,000 | — | Form 4 |
| Dec 13, 2024 | Behbahani Ali Director | Award | 5,750 | $14K | Form 4 |
| Dec 13, 2024 | Raman Prakash Director | Award | 5,150 | $13K | Form 4 |
| Dec 13, 2024 | Campbell Shannon Director | Award | 4,500 | $11K | Form 4 |
BIOTECH GROWTH N V
10 percent owner
Date
Mar 19
Shares
1,000,000
Price
$2.07
Value
$2.07M ⚡
BIOTECH GROWTH N V
10 percent owner
Date
Mar 19
Shares
300,000
Price
$1.94
Value
$583K
BIOTECH GROWTH N V
10 percent owner
Date
Mar 19
Shares
1,000,000
Price
$2.31
Value
$2.31M ⚡
BIOTECH GROWTH N V
10 percent owner
Date
Mar 19
Shares
2,000,000
Price
$2.00
Value
$4.00M ⚡
BIOTECH GROWTH N V
10 percent owner
Date
Mar 19
Shares
400,000
Price
$2.09
Value
$837K
BIOTECH GROWTH N V
10 percent owner
Date
Mar 19
Shares
584,292
Price
$1.95
Value
$1.14M ⚡
BIOTECH GROWTH N V
10 percent owner
Date
Mar 19
Shares
500,000
Price
$2.12
Value
$1.06M ⚡
Velleca Mark A.
PRESIDENT & CEO · Director
Date
Jan 30
Shares
75,000
Price
—
Value
—
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About BDTX insider trading
BDTX insider trades
Black Diamond Therapeutics, Inc. (BDTX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Behbahani Ali (Director), Raman Prakash (Director). Over the past 12 months, 2 insiders have filed transactions with the SEC. BDTX insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Black Diamond Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
BDTX insider trading · 5 questionsThe insiders of Black Diamond Therapeutics, Inc. (BDTX) include executives and directors such as Behbahani Ali (Director), Raman Prakash (Director), among others. Over the past 12 months, 2 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026